The CEO and largest shareholder of both companies said a merger would be a “good idea” and that they had formed committees to ...
Japan has the scientific expertise to develop new medicines, but high costs, fragmented hospital systems and limited global ...
Revenue rose 3% to $9.9 billion and net income increased 34% to $292.9 million; the quarterly payment is expected Nov. 20 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results